MCHRI enters partnership with Menarini Biomarkers

The two will create a regional and international hub for non-invasive diagnostics in Singapore.

SingHealth Duke-NUS' Maternal and Child Health Research Institute (MCHRI) signed a three-year memorandum of understanding with Menarini Biomarkers Singapore during the MCHRI launch at KK Women's and Children's Hospital on 8 October. 

"MBS is delighted to partner with MCHRI for this research and development project in Singapore, the first such partnership we have established outside the European Union," said director Maurizio Luongo. "The CB-NIPD process has the immense potential for broad-based applications and can be a key tool for precision medicine applications, in particular in oncology. We look forward to harnessing the strengths of both MCHRI and Menarini through this valuable partnership."

MCHRI and MBS will pioneer clinical trials using cell-based, non-invasive prenatal diagnosis. The process will use Menarini proprietary technology, which is non-invasive and carries minimal risk to the pregnant woman.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

A white paper recommends a new model for healthcare delivery and financing.
Two companies have bid to make the hospital group private.
The move aims to provide world-class critical care for India.
The two will create a regional and international hub for non-invasive diagnostics in Singapore.
The institute aims to serve as a maternal and child health research centre.
Remote clinics rely heavily on irregular mobile medical services.
The products are part of the Heart Wellness Check-Up programme launched in Bangkok.
But, the companies can decide not to push through with the plan.
The report also shows maintenance cost of equipment has exceeded the cost of new procurement.
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.
Bayer held the #TakeControl virtual roundtable on the occasion of World Contraception Day 2021.
This will establish a smart platform for advanced medical treatment.
They are the 35- to 54-year-old adults caring for both parents and children.
Around 66% of Southeast Asians preferring remote video-call consultations with medical professionals.